LAUSR

REFERENCES 1. Caucanas M, Heylen A, Rolland F, Müller G, Olemans C, Sass U, et al. Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet's syndrome: the concept of neutrophilic disease. Int J Dermatol. 2013;52:1185– 8. 2. Maksimovic L, Duriez P, LascauxCametz AS, Andre C, Bagot M, Revuz J, et al. Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIVpositive patient. Ann Dermatol Venereol. 2010;137:386– 90. 3. Vide J, Brás G, Guimarães JE, Mota A. Pyoderma gangrenosum and erythema elevatum diutinum associated with a highrisk myelodysplastic syndrome: case report. Hematol Transfus Cell Ther. 2018;40:192– 5. 4. Johnson ML, Grimwood RE. Leucocyte Colonystimulating factors. A review of associated neutrophilic dermatosis and vasculitis. Arch Dermtaol. 1994;130:77– 8. 5. Omigawa C, Hashimoto T, Hanafusa T. Rinsho Derma. 2018;60:1091– 4. 6. Patnala GP, Sunandini AP, Rayavarapu R, Yandapalli PS. Erythema elevatum diutinum in association with IgA monoclonal gammopathy: a rare case report. Indian Dermatol Online J. 2016;7:300– 3. 7. Wayte JA, Rogers S, Powell FC. Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy. Australas J Dermatol. 1995;36:21– 3. 8. Kentley J, Marshall C, Bewley A. Erythema elevatum diutinumassociated with loss of the uvula. JAAD Case Rep. 2017;3: 212– 4. 9. Tsunoda K, Onodera H, Endoh K, et al. A case of pyoderma gangrenosum with monoclonal IgA gammopathy. Jap J Clin Dermatol. 2006;63:995– 8. 10. Breedveld A, van Egmond M. IgA and FcαRI: pathological roles and therapeutic opportunities. Front Immunol. 2019;10:553.